81
DAFTAR PUSTAKA American Society of Health-System Pharmacist. 1997, ASHP Guideline on Pharmacist-Conducted Patient Education and Conseling, Am. J. HealthSyst.Pharm., 54:hal 162-73. Anief, M., 2006. Ilmu Meracik Obat, Gadjah Mada university press, Yogjakarta
Anonim., 2011, Profil rumah sakit umum dr. Doris Sylvanus palangkaraya, diakses pada 17 oktober 2013, http://www.kalteng.go.id/viewarticle.asp?ARTICLE_id=1571 Anonim., 2013, Hari kesehata Sedunia (HKS) dan mewaspadai hipertensi, diakses pada 7 mei 2013, http://dinkeskalteng.net/index.php/en/8-berita/10-hks-dan-hipertensi Armilawaty, Amalia H, Amirudin R.,2007. Hipertensi dan Faktor Resikonya dalam Kajian Epidemiologi. Bagian Epidemiologi FKM UNHAS, Cermin Dunia Kedokteran. 15(3): hal 3-10 diakses pada 23 September 2012, http://CerminDuniaKedkteran.com/. Bart, S., 1994. Psikologi Kesehatan, PT. Gramedia Widiasarana Indonesia, Jakarta, hal 32-6. Case Management Society of America. 2010, Case management adherence Guidelines, version 2.0, Case Management Society of America. Chin, C.Y et al, 2013, Antihypertensive Prescribing Pattern and Blood Pressure Control among hypertensive patients over a Ten Year period in a Primary Care Setting in Malaysia. Malaysia, Journal;10 hal 1. Chobanian, A. V., Bakris, G.L., Black , H.R., Chusman, W.L., Green I.A., Izzo, J.L, Jones, D.W., et al. 2003, JNC VII Express: The Seventh Report of the JointNational Commite on Preventian, Detection, Evaluation and Treatment of High Blood Presure, U.S. Deparment of Health and Human Services, hal 12-33. Dahlan, M. S, 2013. Statistik untuk kedokteran dan kesehatan, Salemba Medika, Jakarta, hal 135. Depkes RI, 2007. Pharmaceutical Care untuk Penyakit Hipertensi, Pendoman KonselingPelayanan Kefarmasian di Sarana Kesehatan. Direktorat Jenderal Bina Farmasi, Jakarta, hal 12.
82
Depkes RI, 2006. Pharmaceutical Care untuk Penyakit Hipertensi. Direktorat Jenderal Bina Farmasi. Jakarta, hal 18. Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M. 2005, Pharmacotherapy A Pathophysiologic Approach, Sixth Edition, McGraw-Hill, New York: hal 185-214. Fajar, N. 2009, „Analisis Faktor Sosial Budaya dalam Keluarga yang Mempengaruhi Pengobatan Dini dan Keteraturan Berobat Pada Penderita Hiperetnsi‟, Cermin Dunia Kedokteran, 11 (5): hal 12-20 diakses pada 5 Desember 2012, http://CerminDuniaKedokteran.com/ Febriyanti, Y. Evaluasi Pengaruh Konseling Terhadap Tingkat Kepatuhan dan Hasil Terapi pada Pasien Hipertensi di Poliklinik Penyakit Dalam RSUD Sleman, Tesis, MSc, Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta. Filho, O., et al. 2014, The 8-item Medication Adherence Scale: Validation of a Brazilian-Portuguese version in hypertensive adults, Research in Social and Administrative Pharmacy, Vol 10.Issue 3, hal 554-561. Hardman, J.G., Limbird L.E. 2008, Dasar Farmakologi Terapi volume 1, 10nd edition, Penerbit Buku kedokteran EGC, Jakarta, hal 845. Haynes, R.B., Taylor, D.W., Sackett, D.L., Gibson, E.S., Bernholz, C.D., Mukhreje J., 1980, Can Simple Clinical Measurements Detect Patient Noncomliance., Hypertension,2: hal 757-64. Haynes, R.B., Mc. Donald, H.P., Garg, A.X., 2002, Helping Patients Follow Prescribed Treatment : Clinical Applications, JAMA, 288: hal 2880-83. Hussar, DA., 1995.Patient Compliance, in Remington: The Science and Practise of pharmacy, Philadelphia Collage of Pharmacy and science, USA, 2: hal 1796-1807. Jhonson, M., Hardeep, S., 2005, Patterns of Antihypertensive Therapy Among Patients with Diabetes, Houston, Tex, USA, 20: hal 842–846 Jin, J., Sklar, G.E., Oh, V.M., Li, S.C., 2008, Factor affecting therapeutic compliance: A review from the patient‟s perspective, NCBI, 4(1): hal 269-86. Kartinah, N. 2009, „Estimasi perencanaan obat berdasarkan metode morbiditas sebagai alternatif perencanaan obat di RSUD Dr. Doris Sylvanus Palangkaraya, Tesis, MSc, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.
83
Kementerian Kesehatan. 2009, Peraturan Menteri Kesehatan Republik Indonesia No 51, tentang Pekerjaan Kefarmasian, Jakarta, Kementerian Kesehatan Republik Indonesia. Khan, G.M., Thapa, R.K., Khakurel, A., 2013, Medication Adherence and Blood Pressure Control among Hypertensive Patients of Pokhara Valley, JHAS, Volume 3, Number 1, P 64-67. Kusumaningjati, Y., 2008, „Pengaruh Konseling Farmasis Terhadap Luaran Terapetik Pasien Hipertensi di RSU Kardinal Tegal‟, Tesis, MSc, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta. Laurence, L.B., Lazo J.R., Parker K.L., 2008, Goodman & Gilma’s; Manual Pharmacologyand Therapeutics, Seventh Edition, Mc Graw Hill, New York, hal 546-60. Lee J.K., Grace K.A., Taylor A.J., 2006, Effect of Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol: A Randomized Controlled Trial, American Medical Assosiation, JAMA, 296(21) : hal 2563-71. Morisky, D.E., Ang A Krousel-Wood, M.A., Ward H 2008, Predictive Validity if A Medication Adherence Measure in an Outpatient Setting, J. HealthSyst. Pharm., 10: hal 348-54. Muchid, A., Wurjati, R., Chusun, Komar, Z., Purnama, NR., Masrul, dkk., (ed), 2007, Pharmaceutical Care Untuk Penyakit Asma, Jakarta, Departemen Kesehatan Republik Indonesia, hal 10, hal 15-18. Mulyasih, A.B. 2010, „Pengaruh Konseling Apoteker Terhadap hasil Terapi Pasien Hipertensi di Poliklinik Penyakit dalam RSUD Kraton Kabupaten Pekalongan‟, Tesis, MSc, Fakultas Universitas Gadjah Mada, Yogyakarta. Mutschler E, 1991, Dinamika Obat Buku Ajar Farmakologi danToksikologi, Institut Teknologi, Bandung. Diterjemahkan oleh Dr. Mathilda B. Widianto dan Dr. Anna Setiadi Ranti. Notoatmodjo, S., 2003, Pendidikan dan Perilaku Kesehatan, Rineka Cipta, Jakarta, hal 42-5. Oktora, R. 2007, Gambaran Penderita Hipertensi yang Dirawat Inap di Bagian Penyakit Dalam RSUD Arifin Pekanbaru Periode Januari – Desember 2005’. Tesis, Msc, Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta.
84
Palaian S, Mukhyaprana P, Ravi S. 2006, Patient Counseling by Pharmacist Focus on Chronic Illness, Pak J. Pharm. Sci., 19 (1): hal 62-65. Saleem, F et al. 2012, Translation and validation study of Morisky Medication Adherence Scale (MMAS): the Urdu version for facilitating personcentered healthcare in Pakistan, The International Journal of Person Centered Medicine, hal 384-390. Saragi, S. 2011, Panduan Penggunaan Obat, Rosemata Publisher, Jakarta, hal 136. Sari, I.P. 2004, Penelitian Farmasi Komunitas dan Klinik, Gadjah Mada university press, Yogjakarta. Saseen, J.J., Carter, B.L., 2005, Essential Hypertension, in : Koda Kimble, M.A., Young, L.Y., Kradjan, W.A., Guglielmo, B.J., Alldredge, B.K., dan Corelli, R.L., eds) : Applied Therapeutics : The Clinical Use of Drugs, Eight Edition, New York : Lippincot Williams & Wilkin, Chapter : hal 14.1-43. Saseen, J.J., Carter, B.L., 2008, Hypertension, in : Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M. 2008, Pharmacotherapy A Pathophysiologic Approach, Seventh Edition, New York, McGraw-Hill, hal 139-171. Setiawan, Z. 2004, „Karakteristik Sosiodemografi Sebagai Faktor Risiko Hipertensi Studi Ekologi Di Pulau Jawa‟, Tesis, MSc., Universitas Indonesia, Jakarta. Sudoyo, A.W, Setiyohadi, B., Alwi, I., 2006, Buku Ajar Ilmu Penyakit Dalam, Jilid II, Edisi IV, Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, 1079-85. Surahman, E., Husein, I. 2011 Konsep Dasar Pelayanan Kefarmasian Berbasiskan Pharmaceutical Care. Widya Padjadjaran, Bandung, hal 5. World Health Organization. 2003, International Society of Hypertension WritingGroup, World Health Organization-Internasional Society of hypertension statement of Management of Hypertension, hal 108-17. Yogiantoro, M., 2006, Hipertensi Esensial, dalam : Sudoyo, A.W., Setiyohadi, B., Alwi, I., dkk, (eds) : Buku Ajar Ilmu Penyakit Dalam, Jilid II, Edisi IV, Jakarta : Pusat Penerbitan Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, hal 1079-85.
85
Zeller, A., Ramseier, E, M.A., Teagtmeyer, A., 2008, Patients Self-Reported Adherence to Cardiovascular Medication Using Electronic Monitor as Comparators, Volume 31., Number 11, hal 2037-2043.